{"id":"https://openalex.org/A5123180331","orcid":null,"observed_orcids":[],"display_name":"Lixia Shu","raw_author_names":["Lixia Shu","Shu Lixia"],"full_name":"Lixia Shu","works_count":3,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":0.6666666666666666,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5123180331","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I58200834","ror":"https://ror.org/01vjw4z39","display_name":"Southern Medical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I58200834","ror":"https://ror.org/01vjw4z39","display_name":"Southern Medical University","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","count":2,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","count":1,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","count":1,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","value":1.71e-05,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","value":1.7e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","value":1.28e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","value":5.7e-06,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","score":0.8263999819755554},{"id":"136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","score":0.7202000021934509},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.6711000204086304},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.37400001287460327},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.3215999901294708}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":2}],"display_name_alternatives":["Lixia Shu","Shu Lixia"],"block_key":"l shu","works_api_url":"https://api.openalex.org/works?filter=author.id:A5123180331","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2025-12-29T00:00:00"}